Ny svensk Novusundersökning: Så vanligt är känslomässigt ätande vid övervikt Publisert: 03.12.2025 Navamedic ASA: Navamedic extends its business into Germany together with Evolsin Medical Publisert: 17.10.2025 Navamedic ASA launches Eroxon® in Denmark Publisert: 05.05.2025 Navamedic Welcomes CHMP’s Positive Review of Mysimba’s Cardiovascular Safety Publisert: 02.04.2025 Navamedic launches Eroxon[®] in Finland Publisert: 06.11.2024 Navamedic wins joint Nordic antibiotics tender Publisert: 07.10.2024 FørsteForrige12345NesteSiste
Navamedic ASA: Navamedic extends its business into Germany together with Evolsin Medical Publisert: 17.10.2025